Finally, Fe3O4-siPD-L1@M-BV2 dose-dependently increased the contents of TNF-α, IFN-γ, IL-6 and IL-12 but decreased the contents of IL-10 in orthotopic drug-resistant GBM cells. This evidence concerns the gene TNF and glioblastoma.